Global Editions

CRISPR could help us cure sickle-cell disease. But patients are wary

How accessible would a cure be to the people who need it?
by Mike Orcutt

A gene-editing technique that has shown promise as a potential cure for sickle-cell disease is now being tested in humans. But if it works, will the people who need it even be able to get it? Now that a cure may be in sight, this is an urgent question, says Vence Bonham, a senior advisor to the director of the National Human Genome Research Institute.


اسے اردو میں پڑھیں